Bayer and Onyx have multiple clinical trials underway for individuals with metastatic melanoma. One of these trials is highlighted below. For a more comprehensive list of Nexavar® (sorafenib) tablets clinical trials, please visit clinicaltrials.gov or call 1-866-639-2827.

For more information on each trial, click on the study title to view the listing on clinicaltrials.gov.

Phase 3 Study of Nexavar in Combination with Paclitaxel/Carboplatin Chemotherapy*
Enrollment completed
Study Design: Randomized, placebo-controlled trial
Patients: Unresectable Stage III or Stage IV melanoma patients who have not previously received systemic chemotherapy
Purpose: To determine if patients treated with Nexavar plus chemotherapy live longer than those patients treated with chemotherapy alone
Location: U.S.

* Not a company-sponsored trial.